Sanctuary Advisors, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1777271 INDIANAPOLIS, IN

Position in REGN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$24,893,587

-$6,499,548 QoQ

Shares Held

39,923

-1.7% QoQ

Ownership

0.039%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

#185

of 1,327 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 1% Shared 0% None 99%

Healthcare · as of Jun 30, 2026

Sanctuary Advisors, LLC holds $76,467,110 across 63 Biotechnology names. REGN ranks #1 (32.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	39,923	$24,893,587
2	VRTX	Vertex Pharmaceuticals Inc / Ma	39,811	$19,775,318
3	EXEL	Exelixis, Inc.	41,660	$2,266,720
4	ARGX	Argenx SE	2,186	$2,028,105
5	RLAY	Relay Therapeutics, Inc.	106,632	$1,995,084
6	INCY	Incyte Corp	15,733	$1,783,492
7	ARWR	Arrowhead Pharmaceuticals, Inc.	20,830	$1,697,853
8	HALO	Halozyme Therapeutics, Inc.	19,611	$1,534,952

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$24,893,587	39,923	-1.7%	Shares	Sole	2026-08-13
2026-03-31	$31,393,135	40,631	+4.2%	Shares	Sole	2026-05-05
2025-12-31	$30,089,036	38,982	+14.2%	Shares	Sole	2026-01-29
2025-09-30	$19,186,901	34,124	+0.8%	Shares	Sole	2026-01-06
2025-06-30	$17,767,050	33,842	-0.8%	Shares	Sole	2026-01-06
2025-03-31	$21,642,464	34,124	-4.6%	Shares	Sole	2026-01-06
2024-12-31	$25,480,756	35,771	-0.5%	Shares	Sole	2025-01-31
2024-09-30	$37,779,463	35,938	-20.7%	Shares	Sole	2024-11-25
2024-06-30	$47,610,607	45,299	—	Shares	Sole	2024-09-05
No filing history on record for this holder in this stock.